Litchfield Park, AZ2 Active Studies

Ulcerative Colitis Clinical Trials in Litchfield Park, AZ

Find 2 actively recruiting ulcerative colitis clinical trials in Litchfield Park, AZ. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
2,083
Enrolling

Recruiting Ulcerative Colitis Studies in Litchfield Park

About Ulcerative Colitis Clinical Trials in Litchfield Park

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 2 ulcerative colitis clinical trials recruiting participants in Litchfield Park, AZ. These studies are seeking a combined 2,083 participants. Research is being sponsored by Eli Lilly and Company, Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in Litchfield Park — FAQ

Are there ulcerative colitis clinical trials in Litchfield Park?

Yes, there are 2 ulcerative colitis clinical trials currently recruiting in Litchfield Park, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Litchfield Park?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Litchfield Park research site will contact you about next steps.

Are clinical trials in Litchfield Park free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Litchfield Park studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 2 active trials in Litchfield Park are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated March 2, 2026 from ClinicalTrials.gov